house · trading 2016-03-14 → 2026-03-31
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
By recent-buy return, Harold Dallas Rogers ranks #43 of 122 lawmakers — better than 65% of Congress.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-31 | SPY | BUY | $1K–$15K | $650.34 | $769.35 2026-08-28 | +18.3% |
| 2025-11-24 | T | SELL | $1K–$15K | $25.62 | $26.01 2026-08-28 | -1.5% exit |
| 2024-05-09 | VWO | SELL | $1K–$15K | $43.37 | $60.79 2026-08-28 | -18.3% rt |
| 2024-05-09 | IVV | SELL | $1K–$15K | $522.66 | $773.00 2026-08-28 | +3.3% rt |
| 2024-05-09 | IJS | SELL | $1K–$15K | $100.98 | $137.53 2026-08-28 | +6.7% rt |
| 2024-05-09 | BBL | SELL | $1K–$15K | — | — | — exit |
| 2024-04-16 | VWO | BUY | $1K–$15K | $40.83 | $60.79 2026-08-28 | +48.9% |
| 2024-04-16 | IVV | BUY | $1K–$15K | $505.98 | $773.00 2026-08-28 | +52.8% |
| 2024-04-16 | IJS | BUY | $1K–$15K | $94.66 | $137.53 2026-08-28 | +45.3% |
| 2024-04-16 | IEMG | BUY | $1K–$15K | $50.04 | $81.82 2026-08-28 | +63.5% |
| 2024-04-16 | BGL | BUY | $1K–$15K | — | — | — |
| 2024-04-16 | BGB | BUY | $1K–$15K | $11.67 | $11.20 2026-08-28 | -4.0% |
| 2024-04-16 | BBL | BUY | $1K–$15K | — | — | — |
| 2024-03-31 | SPY | BUY | $1K–$15K | $523.07 | $769.35 2026-08-28 | +47.1% |
| 2021-03-25 | GSK | BUY | $1K–$15K | $36.07 | $50.82 2026-08-28 | +40.9% |
| 2021-03-16 | VWO | BUY | $1K–$15K | $53.07 | $60.79 2026-08-28 | +14.6% |
| 2021-03-16 | K | BUY | $1K–$15K | — | — | — |
| 2021-03-16 | GSK | BUY | $1K–$15K | $36.35 | $50.82 2026-08-28 | +39.8% |
| 2021-03-16 | BND | BUY | $1K–$15K | $84.74 | $72.31 2026-08-28 | -14.7% |
| 2017-09-11 | HCA | BUY | $1K–$15K | $78.35 | $417.82 2026-08-28 | +433.3% |
| 2017-09-07 | ZOET | BUY | $1K–$15K | — | — | — |
| 2017-09-07 | O | BUY | $1K–$15K | $56.89 | $61.98 2026-08-28 | +8.9% |
| 2016-03-24 | QCOM | BUY | $1K–$15K | $50.86 | $164.19 2026-08-28 | +222.8% |
| 2016-03-24 | PYPL | BUY | $1K–$15K | $38.92 | $53.66 2026-08-28 | +37.9% |
| 2016-03-15 | ROK | BUY | $1K–$15K | $107.18 | $430.86 2026-08-28 | +302.0% |
| 2016-03-15 | BROWN | BUY | $1K–$15K | — | — | — |
| 2016-03-14 | MRK | BUY | $1K–$15K | $50.65 | $148.35 2026-08-28 | +192.9% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Thomas R Carper | 8 · GSK, IEMG, IJS, IVV, PYPL, QCOM |
| Kurt Schrader | 8 · GSK, VWO, IJS, T, PYPL, QCOM |
| James B. Renacci | 7 · GSK, IVV, T, MRK, PYPL, QCOM |
| John Boozman | 7 · BND, GSK, VWO, IVV, PYPL, QCOM |
| Kenny Marchant | 7 · GSK, K, T, MRK, QCOM, HCA |
| David A Perdue , Jr | 6 · T, MRK, PYPL, QCOM, HCA, SPY |
| Alan S. Lowenthal | 6 · IEMG, T, MRK, PYPL, HCA, SPY |
| Josh Gottheimer | 6 · T, MRK, PYPL, ROK, HCA, SPY |
| Thomas H Tuberville | 6 · GSK, IVV, MRK, PYPL, QCOM, ROK |
| Alan Armstrong | 6 · T, MRK, PYPL, QCOM, HCA, O |
| Charles J. "Chuck" Fleischmann | 6 · BND, GSK, IEMG, IJS, PYPL, SPY |
| Mike Kelly | 6 · GSK, VWO, T, HCA, O, SPY |